A systematic review of randomized controlled trials on the theraputic effect of intravenous sodium valproate in status epilepticus

International Journal of Neuroscience

Volumn 122, Issue 6, 2012, Pages 277-283

  Liu, Xiaofei ^a   Wu, Yuan ^a   Chen, Zibin ^a   Ma, Meigang ^a   Su, Li ^b  

^a FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

^b GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Diazepam; Intravenous sodium valproate; Levetiracetam; Phenytoin; Status epilepticus; Valproic acid

Indexed keywords

DIAZEPAM; ETIRACETAM; PHENYTOIN; VALPROIC ACID;

ANTICONVULSANT THERAPY; DISEASE CONTROL; DRUG EFFICACY; DRUG SAFETY; EPILEPTIC STATE; HUMAN; LIVER DYSFUNCTION; LOADING DRUG DOSE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATION DEPRESSION; REVIEW; SYSTEMATIC REVIEW;

ANTICONVULSANTS; DIAZEPAM; HUMANS; INJECTIONS, INTRAVENOUS; PHENYTOIN; PIRACETAM; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STATUS EPILEPTICUS; VALPROIC ACID;

EID: 84861062962     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.3109/00207454.2012.657376     Document Type: Review

References (28)

1. Hodges BM, Mazur JE. Intravenous valproate in status epilepticus. Ann Pharmacother. 2001;35(11):1465-70.
2. Walker M. Status epilepticus: An evidence based guide. Brit Med J. 2005;331(7518):673-7.
3. Agarwal P, Kumar N, Chandra R, Gupta G, Antony AR, Garg A. Randomized study of intravenous valproate and phenytoin in status epilepticus. Seizure. 2007;16(6):527-32.
4. Prasad K, Krishnan PR, Al-Roomi K, Sequeira R. Anticonvulsant therapy for status epilepticus. Br J Clin Pharmacol. 2007;63(6):640-7.
5. Prasad A,Worrall BB, Bertram EH, Bleck TP. Propofol and midazolam in the treatment of refractory status epilepticus. Epilepsia. 2001;42(3):380-6.
6. Lowenstein DH. The management of refractory status epilepticus: An update. Epilepsia. 2006;47(Suppl. 1):35-40.
7. Rabinstein AA. Management of status epilepticus in adults. Neurol Clin. 2010;28(4):853-62.
8. Knake S, Hamer HM, Rosenow F. Status epilepticus: A critical review. Epilepsy Behav. 2009;15(1):10-4.
9. Peters CN, Pohlmann-Eden B. Intravenous valproate as an innovative therapy in seizure emergency situations including status epilepticus-experience in 102 adult patients. Seizure. 2005;14(3):164-9.
10. Honack D, Loscher W. Intravenous valproate: onset and duration of anticonvulsant activity against a series of electroconvulsions in comparison with diazepam and phenytoin. Epilepsy Res. 1992;13(3):215-21.
11. Mehta V, Singhi P, Singhi S. Intravenous sodium valproate versus diazepam infusion for the control of refractory status epilepticus in children: A randomized controlled trial. J Child Neurol. 2007;22(10):1191-7.
12. Yamamoto LG, Yim GK. The role of intravenous valproic acid in status epilepticus. Pediatr Emerg Care. 2000;16(4):296-8.
13. Trinka E. The use of valproate and new antiepileptic drugs in status epilepticus. Epilepsia. 2007;48(Suppl. 8):49-51.
14. Alvarez V, Januel JM, Burnand B, Rossetti AO. Second-line status epilepticus treatment: Comparison of phenytoin, valproate, and levetiracetam. Epilepsia. 2011;52:1292-6.
15. Balshem H, Helfand M, Schünemann HJ, Oxman AD, Kunz R, Brozek J, Vist GE, Falck-Ytter Y, Meerpohl J, Norris S, Guyatt GH. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol. 2011;64(4):401-6.
16. Chen L, Feng P, Wang J, Liu L, Zhou D. Intravenous sodium valproate in mainland China for the treatment of diazepam refractory convulsive status epilepticus. J Clin Neurosci. 2009;16(4):524-6.
17. Czapinski P, Terczynski A. Intravenous valproic acid administration in status epilepticus [Polish]. Neurologia i Neurochirurgia Polska. 32(1):11-22.
18. Thilothammal N, Banu K, Ratnam R. Comparison of phenobarbitone, phenytoin with sodium valproate: Randomized, double-blind study. Indian Pediat. 1996;33(7):549-55.
19. Crawford P, Chadwick D. A comparative study of progabide, valproate, and placebo as add-on therapy in patients with refractory epilepsy. J Neurol, Neurosurg, Psychiat. 1986;49(11):1251-7.
20. Turnbull DM, Howel D, Rawlins MD, Chadwick DW. Which drug for the adult epileptic patient: Phenytoin or valproate? Brit Med J Clin Res Ed. 1985;290(6471):815-9.
21. Olsen KB, Tauboll E, Gjerstad L. Valproate is an effective, welltolerated drug for treatment of status epilepticus/serial attacks in adults. Acta Neurol Scand Suppl 2007;187:51-4.
22. Giroud M, Gras D, Escousse A, Dumas R, Venaud G. Use of injectable valproic acid in status epilepticus, a pilot study. Drug Invest. 1993;5:154-9.
23. Mattson RH, Cramer JA, Collins J. A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults (The Department of Veterans Affairs Epilepsy Cooperative Study No. 264 Group). New Engl J Med New. 1992;327(11):765-71.
24. Gilad R, Izkovitz N, Dabby R, Rapoport A, SadehM,Weller B, Lampl Y. Treatment of status epilepticus and acute repetitive seizures with i.v. valproic acid vs phenytoin. Acta Neurol Scand. 2008;118(5):296-300.
25. Misra UK, Kalita J, Patel R. Sodium valproate vs phenytoin in status epilepticus: A pilot study. Neurology. 2006;67(2):340-2.
26. Tripathi M, Vibha D, Choudhary N, Prasad K, Srivastava MV, Bhatia R, Chandra SP. Management of refractory status epilepticus at a tertiary care centre in a developing country. Seizure. 2010;19(2):109-11.
27. Appleton R, Macleod S, Martland T. Drug management for acute tonic-clonic convulsions including convulsive status epilepticus in children. Cochrane Database Syst Rev. Vol. no.: 2008 Jul 16. Page range: CD001905.
28. Ramael S, Daoust A, Otoul C, Toublanc N, Troenaru M, Lu ZS, Stockis A. Levetiracetam intravenous infusion: A randomized, placebo-controlled safety and pharmacokinetic study. Epilepsia. 2006;47(7):1128-35.